Evidence-based medicine, utilities, and quality of life

Current Opinion in Ophthalmology

Volumn 10, Issue 3, 1999, Pages 221-226

  Brown, Melissa M ^a,c   Brown, Gary C ^a   Sharma, Sanjay ^a   Garrett, Stephen ^b  

^a WILLS EYE HOSPITAL   (United States)

^b LOCKHEED MARTIN   (United States)

^c Ctr Evidence Based Hlth Care Econ   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVIDENCE BASED MEDICINE; HUMAN; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REVIEW;

AGED; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; HUMANS; MACULAR DEGENERATION; MALE; QUALITY OF LIFE;

EID: 0033062515     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199906000-00012     Document Type: Review

References (29)

1. 1 Sharma S: Levels of evidence and interventional ophthalmology. Can J Ophthalmol 1997, 32:359-362. Demonstrates the different levels of evidence-based medicine.
2. 2 Sharma S: Determining the clinical significance of randomized clinical trials: a review of the efficacy of laser photocoagulation. Can J Ophthalmol 1999, in press.
3. 3 Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy: the second report of the Diabetic Retinopathy Study findings. Ophthalmology 1978, 85:82-106.
4. 4 Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985, 103:1796-1806.
5. 5 Cryotherapy for Retinopathy of Prematurity Cooperative Group: Multicenter trial of cryotherapy for retinopathy of prematurity: Snellen visual acuity and structural outcome at 5 1/2 years after randomization. Arch Ophthalmol 1996, 114:417-424.
6. 6 Schmidt D, Schumacher M, Wakhloo AK: Microcatheter urokinase infusion in central retinal artery occlusion. Am J Ophthalmol 1992, 113:429-434.
7. 7 Thomas MA, Grand G, Williams PF, Lee CM, Pesin SR, Lowe MA: Surgical management of choroidal neovascularization. Ophthalmology 1992, 99: 952-968.
8. 8 McDonough RL, Forteza AM, Flynn HW Jr: Internal carotid artery dissection causing a branch retinal artery occlusion in a young adult. Am J Ophthalmol 1998, 125:706-708.
9. 9 Laser ROP Study Group: Laser therapy for retinopathy of prematurity. Arch Ophthalmol 1994, 112:154-156.
10. 10 von Neumann J, Morgenstern O: Theory of Games and Economic Behavior. Princeton, NJ: Princeton University Press; 1944.
11. 11 Weinstein MC, Stasson WB: Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977, 296:716-721.
12. 12 Redelmeier DA, Detsky AS: A clinician's guide to utility measurement. Med Decis Making 1995, 22:271-280.
13. 13 Torrance GW: Measurement of health state utilities for economic appraisal: a review. J Health Econ 1986, 5:1-30.
14. 14 Torrance GW, Feeny D: Utilities and quality-adjusted life years. Int J Technology Assessment in Health Care 1989, 2:559-575.
15. 15 Brown GC, Sharma S, Brown MM, Garrett S, Quality in Medicine Study Research Group: Evidence-based medicine and cost-effectiveness. J Healthcare Fin 1999, in press. Good overview of the value of cost-effectiveness analysis for medical care.
16. 16 O'Connell SR, Bresster NM: Age-related macular degeneration. In Vitreoretinal Disease: The Essentials. Edited by Regillo CD, Brown GC, Flynn HW. New York: Thieme Medical Publishers; 1999:213-240.
17. 17 Kassirer JP: Adding insult to injury: usurping patients' prerogatives. N Engl J Med 1983, 308:898-901.
18. 18 Angell M: Patients' preferences in randomized clinical trials. N Engl J Med 1984, 310:1385-1387.
19. 19 Kassirer JP: Incorporating patients' preferences into medical decisions. N Engl J Med 1994, 330:1895-1986.
20. 20 Brown GC, Brown MM, Sharma S: Difference between patient and ophthalmologist perceptions of quality of life with age-related macular degeneration. Submitted for publication. Points out the important differences between patient perceptions and the perceptions of physicians who take care of their diseases.
21. 21 Brown MM, Brown GC, Sharma S, Kistler J: Utility state associated with severe blindness. Submitted for publication. Elucidates the extreme value of even a small amount of vision to those who are visually impaired.
22. 22 Brown GC, Sharma S, Brown MM, Kistler J: Utility values and age-related macular degeneration. Arch Ophthalmol, in press. Demonstrates the value of vision to those who are visually impaired by age-related macular degeneration.
23. 23 Brown MM, Brown GC, Sharma S, Shah G: Utility values and diabetic retinopathy. Am J Ophthalmol, in press. Demonstrates the value of vision to those who are visually impaired by diabetic retinopathy.
24. 24 Samsa GP, Natchar DG, Goldstein L, Bonito A, Duncan PW, Lipscomb J, et al.: Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am Heart J 1998, 136:703-713.
25. 25 Lee TL, Solomon NA, Heidenreich PA, Oehlert MS, Garber AM: Cost-effectiveness of screening for carotid stenosis in asymptomatic persons. Ann Int Med 1997, 126:337-346. Good example of a cost-effectiveness analysis for a medical diagnostic modality.
26. 26 Sonnenberg FA, Beck JR: Markov models in medical decision making: a practical guide. Med Decis Making 1993, 13:322-338.
27. 27 Laupacis A, Feeny D, Detsky AS, Tugwell PX: How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992, 146:473-481.
28. 28 Weinstein MC, Stason WB: Cost-effectiveness of coronary artery bypass surgery. Circulation 1982, 66:56-66.
29. 29 Javitt J, Dei Cas R, Chiang YP: Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity. Pediatrics 1993, 91:859-866.